Effects of prostaglandin D2 on helper T cell functions

Biochemical and Biophysical Research Communications

Volumn 316, Issue 4, 2004, Pages 1009-1014

  Tanaka, Kazuya ^a   Hirai, Hiroyuki ^a   Takano, Shoichi ^a   Nakamura, Masataka ^b   Nagata, Kinya ^a  

^a BML   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; PROSTAGLANDIN D2; CYTOKINE; IMMUNOGLOBULIN RECEPTOR; PROSTAGLANDIN D2 RECEPTOR; PROSTAGLANDIN RECEPTOR;

ALLERGY; ARTICLE; CELL FUNCTION; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; MAST CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; HELPER CELL; METABOLISM; MONONUCLEAR CELL;

CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; PROSTAGLANDIN D2; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 1642317868     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.02.151     Document Type: Article

References (32)

1. Romagnani S. Th1 and Th2 in human diseases. Clin. Immunol. Immunopathol. 80:1996;225-235.
2. Robinson D.S., Hamid Q., Ying S., Tsicopoulos A., Barkans J., Bentley A.M., Corrigan C., Durham S.R., Kay A.B. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:1992;298-304.
3. 2 by human helper T cell subsets. J. Immunol. 164:2000;2277-2280.
4. 2. Prostaglandins. 35:1988;277-300.
5. Fujitani Y., Kanaoka Y., Aritake K., Uodome N., Okazaki-Hatake K., Urade Y. Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice. J. Immunol. 168:2002;443-449.
6. 2 as a mediator of allergic asthma. Science. 287:2000;2013-2017.
7. 2 effects on cyclic AMP and human T-cell mitogenesis. Prostaglandins Med. 3:1979;315-320.
8. 2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J. Exp. Med. 193:2001;255-261.
9. Boie Y., Sawyer N., Slipetz D.M., Metters K.M., Abramovitz M. Molecular cloning and characterization of the human prostanoid DP receptor. J. Biol. Chem. 270:1995;18910-18916.
10. Nagata K., Tanaka K., Ogawa K., Kemmotsu K., Imai T., Yoshie O., Abe H., Tada K., Nakamura M., Sugamura K., Takano S. Selective expression of a novel surface molecule by human Th2 cells in vivo. J. Immunol. 162:1999;1278-1286.
11. 2 receptor CRTH2: structure, properties, and functions in leukocytes. Prostaglandins Leukot. Essent. Fatty Acids. 69:2003;169-177.
12. 2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood. 98:2001;1942-1948.
13. 2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells. J. Immunol. 170:2003;4943-4952.
14. 2 receptors CRTH2 and DP. J. Allergy Clin. Immunol. 108:2001;982-988.
15. 2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J. Exp. Med. 193:2001;1135-1147.
16. 2 inhibits fibroblast migration. Eur. Respir. J. 19:2002;684-689.
17. 2 inhibits the production of interleukin-12 in murine dendritic cells through multiple signaling pathways. Eur. J. Immunol. 33:2003;889-898.
18. 2 receptor CRTH2 with circulating T helper 2 cells in patients with atopic dermatitis. J. Invest. Dermatol. 119:2002;609-616.
19. 2 receptor, CRTH2. J. Immunol. 168:2002;981-985.
20. 2-like and eotaxin-like selective responses in eosinophils and basophils. J. Biol. Chem. 277:2002;26012-26020.
21. Gilroy D.W., Colville-Nash P.R., Willis D., Chivers J., Paul-Clark M.J., Willoughby D.A. Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 5:1999;698-701.
22. Messi M., Giacchetto I., Nagata K., Lanzavecchia A., Natoli G., Sallusto F. Memory and flexibility of cytokine gene expression as separable properties of human TH1 and TH2 lymphocytes. Nat. Immunol. 4:2003;78-86.
23. Annunziato F., Cosmi L., Manetti R., Brugnolo F., Parronchi P., Maggi E., Nagata K., Romagnani S. Reversal of human allergen-specific CRTH2+ TH2 cells by IL-12 or the PS-DSP30 oligodeoxynucleotide. J. Allergy Clin. Immunol. 108:2001;815-821.
24. Sundrud M.S., Grill S.M., Ni D., Nagata K., Alkan S.S., Subramaniam A., Unutmaz D. Genetic reprogramming of primary human T cells reveals functional plasticity in Th cell differentiation. J. Immunol. 171:2003;3542-3549.
25. Butcher E.C. Leukocyte-endothelial cell adhesion as an active, multi-step process: a combinatorial mechanism for specificity and diversity in leukocyte targeting. Adv. Exp. Med. Biol. 323:1992;181-194.
26. Banchereau J., Bazan F., Blanchard D., Briere F., Galizzi J.P., van Kooten C., Liu Y.J., Rousset F., Saeland S. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:1994;881-922.
27. 2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine. J. Exp. Med. 198:2003;533-543.
28. 2 receptor antagonist BAY-u-3405 on experimental allergic reactions. Prostaglandins. 50:1995;75-87.
29. 2-induced eosinophil migration in vitro. J. Pharmacol. Exp. Ther. 305:2003;347-352.
30. 2-induced eosinophilia in rats. J. Pharmacol. Exp. Ther. 307:2003;518-525.
31. 2 analogs on the pulmonary and systemic circulations in the conscious newborn lamb. Prostaglandins. 27:1984;535-542.
32. Wright D.H., Ford-Hutchinson A.W., Chadee K., Metters K.M. The human prostanoid DP receptor stimulates mucin secretion in LS174T cells. Br. J. Pharmacol. 131:2000;1537-1545.